v3.25.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities    
Net loss $ (21,643) $ (24,045)
Adjustments to reconcile net loss to cash used in operating activities:    
Depreciation 626 587
Amortization of intangibles 929 382
Loss on revaluation of contingent consideration 2,171 1,798
Non-cash lease expense 1 14
Stock-based compensation 9,852 10,262
Changes in operating assets and liabilities:    
Accounts receivable (2,023) 691
Inventories (1,236) 677
Prepaid expenses and other current assets 1,151 (146)
Other assets (170) 29
Accounts payable (880) 758
Accrued liabilities 188 (99)
Deferred revenue (2,638) 574
Other liabilities (13) 21
Net cash used in operating activities (13,685) (8,497)
Cash flows from investing activities    
Purchase of property and equipment (93) (34)
Cash acquired in business acquisitions 108
Net cash (used in) provided by investing activities (93) 74
Cash flows from financing activities    
Proceeds from issuance of stock 15,656 297
Equity issuance costs (893)
Net cash provided by financing activities 14,763 297
Net increase (decrease) in cash, cash equivalents, and restricted cash 985 (8,126)
Cash, cash equivalents, and restricted cash at beginning of period 12,436 20,562
Cash, cash equivalents, and restricted cash at end of period 13,421 12,436
Supplemental disclosure of cash flow information:    
Fair value of shares of common stock issued for contingent consideration earnouts 4,318
Reconciliation of cash, cash equivalents, and restricted cash to consolidated balance sheet as of December 31st:    
Cash and cash equivalents 13,421 12,217
Restricted cash - current 219
Total cash, cash equivalents, and restricted cash $ 13,421 $ 12,436